Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare

Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare

Most medicines have never been adequately tested for safety and efficacy in pediatric populations and preterm, infants and children are particularly vulnerable

Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the over

The development of paediatric medicines can be challenging since this is a different patient population with specific needs. A medicine designed for use in paed